Journal of Healthcare Engineering has retracted the article titled “Efficacy and Safety of Temozolomide Combined with Radiotherapy in the Treatment of Malignant Glioma” [1] due to concerns that the peer review process has been compromised.
Following an investigation conducted by the Hindawi Research Integrity team [2], significant concerns were identified with the peer reviewers assigned to this article; the investigation has concluded that the peer review process was compromised. We therefore can no longer trust the peer review process, and the article is being retracted with the agreement of the Chief Editor.
References
- 1.Wei S., Li J. Efficacy and Safety of Temozolomide Combined with Radiotherapy in the Treatment of Malignant Glioma. Journal of Healthcare Engineering . 2022;2022:6. doi: 10.1155/2022/3477918.3477918 [DOI] [PMC free article] [PubMed] [Google Scholar] [Retracted]
- 2.Ferguson L. Advancing Research Integrity Collaboratively and with Vigour. 2022. https://www.hindawi.com/post/advancing-research-integrity-collaboratively-and-vigour/
